Clinical Trial Update: Topical Roflumilast in Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating topical roflumilast in adults with atopic dermatitis was completed, with results posted in 2015 by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Topical roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2015-07-07